It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...

Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

William Blair's assessment is that MariTide is an improvement on current obesity therapies with a profile that "will be ...

Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...

Outgoing US President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs -- but Donald ...

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...